Delivery Order SPE2DB24D1205-SPE2DB25FDAWD
Award Date 9/25/25
Potential Completion Date 10/17/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,620.93 by the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of Zeposia 0.92 mg capsules (30-count packaging). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 19, 2025. The contract will be performed at AmerisourceBergen's Conshohocken facility. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units) with a ceiling value of $9,241.86. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive award supporting federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $4,466.57 firm fixed price delivery order contract to supply Zeposia 0.92 mg capsules. This order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. The IDC serves as the primary vehicle for Amerisourcebergen to provide pharmaceuticals and...
- This delivery order, valued at $9,241.86, awards AmerisourceBergen Drug Corp the supply of Zeposia 0.92 mg capsules (30-count units) under a firm fixed price contract. The award was made competitively without set-aside designation and is set for completion by August 19, 2025. The Defense Logistics Agency, which handles medical supply chain procurement for the Department of Defense, is the funding federal agency, with performance taking place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units) with a contract value of $4,620.93. This non-competitive delivery order utilizes firm fixed pricing and is scheduled for completion by September 25, 2025. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units) with a contract ceiling value of $13,862.79. This competitive award, which carries a firm fixed-price structure and no set-aside designation, is scheduled for completion by September 30, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order valued at $4,620.93 to AmerisourceBergen Drug Corp for the supply of Zeposia 0.92 mg capsules (30-count) with a firm fixed price structure. This non-set-aside award, issued on July 11, 2025, will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Zeposia 0.92 MG capsules. The order, valued at $13,399.71, has a firm fixed price and a completion date of September 11, 2024. AmerisourceBergen, a major pharmaceutical distributor, is delivering this medication to support various government healthcare programs and facilities, including military treatment facilities and veterans' hospitals. The contract is not set aside for any...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) for ZEPOSIA 0.92 mg capsules (30-count units) valued at $13,862.79. The award was made on July 28, 2025, under a Firm Fixed Price contract type with an ultimate completion date of August 18, 2025. This non-competitive, non-set-aside delivery order represents a continuation of the company's extensive pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Zeposia 0.92 mg capsules (30-count) with a ceiling value of $13,862.79. This firm fixed-price delivery order represents a non-competitive award and is scheduled for completion by August 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a leading pharmaceutical distributor, AmerisourceBergen maintains a...